The tumorigenic role of EGR-1 has been first revealed in prostate cancer, where high expression of EGR1 triggered cell proliferation and metastasis, leaving EGR1 as a candidate target for the therapy of prostate cancer [8,9]. The gene discussed is EGR1; the disease is Familial prostate cancer.